Insmed (INSM) Misses Q4 EPS by 14c
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $120.82 --0%
EPS Growth %: +77.7%
Financial Fact:
Research and development: 23.43M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: +77.7%
Financial Fact:
Research and development: 23.43M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Insmed (NASDAQ: INSM) reported Q4 EPS of ($1.32), $0.14 worse than the analyst estimate of ($1.18). Revenue for the quarter came in at $104.44 million versus the consensus estimate of $97.68 million.
For earnings history and earnings-related data on Insmed (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Reiterates Buy Rating on KB Home (KBH) Amid Transition Back to Built-to-Order
- Cintas Corp. (CTAS) Tops Q1 EPS by 1c, Offers Guidance
- General Mills beats estimates as cost savings offset volumes
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
